Why pay $50 billion for the headache known as Tylenol?
Update: 2025-11-04
Description
Kimberly-Clark’s stock closed down 14% yesterday after it gambled nearly $50 billion on a company called Kenvue, maker of Listerine, Band-Aids, and Tylenol — the painkiller HHS Secretary Robert F. Kennedy wants to link to autism, despite a lack of scientific evidence. People are now suing Kenvue, a potential liability that will become Kimberly-Clark's problem. We unpack. Also: potential changes to public service loan forgiveness and a speech by Federal Reserve Governor Lisa Cook.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
